Study of GDC-0980 Versus Everolimus in Participants With Metastatic Renal Cell Carcinoma Who Have Progressed on or Following Vascular Endothelial Growth Factor- (VEGF) Targeted Therapy
Clinical trial NCT01442090 · COMPLETED
Trial details
- NCT number
- NCT01442090
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2013-05-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.